TABLE 1.

Oligonucleotides used to generate soluble LRP1 minireceptors

Restriction sites are labeled in boldface type and underlined.

Oligonucleotide (residues)	Forward primer (5′–3′)	Reverse primer (5′–3′)
sLRP1-II (787–1244)	GATCGGATCCAAATGCCGGGTGAACAATGGCGGC	GATCGATATCCCGCTGCGGCAGCTCTCGCCGTCAG
sLRP1-III (2462–3004)	GATCGGATCCCCATGCCGAATCAACAACGGTGGC	GATCGATATCCCAGCCTTGCAGCTGTGGGGGTCGC
sLRP1-IV (3274–3843)	GATCGGATCCCCCTGCAAGGTCAACAATGGTGGC	GATCGATATCCCGGCCTTGCAGGTGTTGTGCGTCTT
CR4/CR8 (893–1099)	GATCGGATCCCACACCTGCCCCTCGGACCGA	GATCGATATCCCTCCCTCACAGCTCTTCTCATC